Intragastric administration of the bitter tastant quinine lowers the glycemic response to a nutrient drink without slowing gastric emptying in healthy men
Peasura, N., Laohakunjit, N., Kerdchoechuen, O
Platforms that follow these principles earn higher patient ratings When platforms follow these principles, the payoff is better care and better outcomes
Its not that vicious cycle
In a cross-sectional study presented at the European Association for the Study of Diabetes annual meeting and published in Diabetes, Obesity and Metabolism , researchers surveyed adults with obesity who were using semaglutide (Ozempic/Wegovy, Novo Nordisk) or tirzepatide (Mounjaro, Eli Lilly) and asked about changes in their appetite, satiety and sensory perception after starting an incretin-based therapy
DES MOINES, Iowa, June 9, 2026 (Newswire.com) - Title Reference Notice: "FeelGood GLP-1" is the consumer-facing product identifier published by FeelGood Health at feelgoodmeds.com